Catalyst Biosciences Financials

Catalyst Biosciences Stock Summary

Catalyst Biosciences competes with Akari Therapeutics, Benitec Biopharma, and Pulmatrix. Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. Catalyst Biosciences, Inc. was founded in 2002 and is headquartered in South San Francisco, California. Catalyst Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 45 people.

Catalyst Biosciences Key Financial Ratios

Catalyst Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Catalyst Biosciences's current stock value. Our valuation model uses many indicators to compare Catalyst Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Catalyst Biosciences competition to find correlations between indicators driving Catalyst Biosciences's intrinsic value. More Info.Catalyst Biosciences is rated fourth in return on equity category among its peers. It is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Catalyst Biosciences' earnings, one of the primary drivers of an investment's value.

Catalyst Biosciences Market Pulse

Along with financial statement analysis, the daily predictive indicators of Catalyst Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Catalyst Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Catalyst Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Catalyst Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Catalyst Biosciences's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

If you are still planning to invest in Catalyst Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Catalyst Biosciences' history and understand the potential risks before investing.